抗真菌剤の世界市場見通し2022年-2028年

◆英語タイトル:Anti-fungal Drugs Market, Global Outlook and Forecast 2022-2028

Market Monitor Globalが発行した調査報告書(MMG22NV10741)◆商品コード:MMG22NV10741
◆発行会社(リサーチ会社):Market Monitor Global
◆発行日:2022年11月
◆ページ数:67
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥481,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥625,300見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥721,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の抗真菌剤市場規模と予測を収録しています。・世界の抗真菌剤市場:売上、2017年-2022年、2023年-2028年
・世界の抗真菌剤市場:販売量、2017年-2022年、2023年-2028年
・世界のトップ5企業、2021年

世界の抗真菌剤市場は2021年に000Mドルと評価され、予測期間中に000%のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「粉末」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。

抗真菌剤のグローバル主要企業は、Abbott Laboratories、 Astellas Pharma、 Bayer、 GlaxoSmithKline、 Glenmark、 Kramer Laboratories、 Merck、 Novartis、 Pfizer、 SCYNEXIS、 Sanofi、 Gilead Science、 Enzon Pharmaceuticalsなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、抗真菌剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の抗真菌剤市場:タイプ別、2017年-2022年、2023年-2028年
世界の抗真菌剤市場:タイプ別市場シェア、2021年
・粉末、軟膏、錠剤、その他

世界の抗真菌剤市場:用途別、2017年-2022年、2023年-2028年
世界の抗真菌剤市場:用途別市場シェア、2021年
・病院、小売薬局、オンライン薬局

世界の抗真菌剤市場:地域・国別、2017年-2022年、2023年-2028年
世界の抗真菌剤市場:地域別市場シェア、2021年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における抗真菌剤のグローバル売上、2017年-2022年
・主要企業における抗真菌剤のグローバル売上シェア、2021年
・主要企業における抗真菌剤のグローバル販売量、2017年-2022年
・主要企業における抗真菌剤のグローバル販売量シェア、2021年

さらに、当レポートは主要企業のプロファイルを提示します。
Abbott Laboratories、 Astellas Pharma、 Bayer、 GlaxoSmithKline、 Glenmark、 Kramer Laboratories、 Merck、 Novartis、 Pfizer、 SCYNEXIS、 Sanofi、 Gilead Science、 Enzon Pharmaceuticals

*************************************************************

・調査・分析レポートの概要
抗真菌剤市場の定義
市場セグメント
世界の抗真菌剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の抗真菌剤市場規模
世界の抗真菌剤市場規模:2021年 VS 2028年
世界の抗真菌剤市場規模と予測 2017年-2028年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの抗真菌剤の売上
グローバルトップ3およびトップ5企業、2021年売上ベース
グローバル企業の抗真菌剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:粉末、軟膏、錠剤、その他
抗真菌剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:病院、小売薬局、オンライン薬局
抗真菌剤の用途別グローバル売上・予測

・地域別市場分析
地域別抗真菌剤市場規模 2021年と2028年
地域別抗真菌剤売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Abbott Laboratories、 Astellas Pharma、 Bayer、 GlaxoSmithKline、 Glenmark、 Kramer Laboratories、 Merck、 Novartis、 Pfizer、 SCYNEXIS、 Sanofi、 Gilead Science、 Enzon Pharmaceuticals
...

Antifungal drugs are used to treat fungal infections, which most commonly affect your skin, hair and nails.
This report contains market size and forecasts of Anti-fungal Drugs in Global, including the following market information:
Global Anti-fungal Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Anti-fungal Drugs market was valued at 1770.4 million in 2021 and is projected to reach US$ 2075.4 million by 2028, at a CAGR of 2.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Anti-fungal Drugs include Abbott Laboratories, Astellas Pharma, Bayer, GlaxoSmithKline, Glenmark, Kramer Laboratories, Merck, Novartis and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-fungal Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-fungal Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Anti-fungal Drugs Market Segment Percentages, by Type, 2021 (%)
Powder
Ointment
Tablet
Other
Global Anti-fungal Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Anti-fungal Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital
Retail Pharmacy
Online Pharmacy
Global Anti-fungal Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Anti-fungal Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-fungal Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Anti-fungal Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Astellas Pharma
Bayer
GlaxoSmithKline
Glenmark
Kramer Laboratories
Merck
Novartis
Pfizer
SCYNEXIS
Sanofi
Gilead Science
Enzon Pharmaceuticals

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Anti-fungal Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-fungal Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-fungal Drugs Overall Market Size
2.1 Global Anti-fungal Drugs Market Size: 2021 VS 2028
2.2 Global Anti-fungal Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti-fungal Drugs Players in Global Market
3.2 Top Global Anti-fungal Drugs Companies Ranked by Revenue
3.3 Global Anti-fungal Drugs Revenue by Companies
3.4 Top 3 and Top 5 Anti-fungal Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Anti-fungal Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-fungal Drugs Players in Global Market
3.6.1 List of Global Tier 1 Anti-fungal Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Anti-fungal Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type – Global Anti-fungal Drugs Market Size Markets, 2021 & 2028
4.1.2 Powder
4.1.3 Ointment
4.1.4 Tablet
4.1.5 Other
4.2 By Type – Global Anti-fungal Drugs Revenue & Forecasts
4.2.1 By Type – Global Anti-fungal Drugs Revenue, 2017-2022
4.2.2 By Type – Global Anti-fungal Drugs Revenue, 2023-2028
4.2.3 By Type – Global Anti-fungal Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Anti-fungal Drugs Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.2 By Application – Global Anti-fungal Drugs Revenue & Forecasts
5.2.1 By Application – Global Anti-fungal Drugs Revenue, 2017-2022
5.2.2 By Application – Global Anti-fungal Drugs Revenue, 2023-2028
5.2.3 By Application – Global Anti-fungal Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region – Global Anti-fungal Drugs Market Size, 2021 & 2028
6.2 By Region – Global Anti-fungal Drugs Revenue & Forecasts
6.2.1 By Region – Global Anti-fungal Drugs Revenue, 2017-2022
6.2.2 By Region – Global Anti-fungal Drugs Revenue, 2023-2028
6.2.3 By Region – Global Anti-fungal Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country – North America Anti-fungal Drugs Revenue, 2017-2028
6.3.2 US Anti-fungal Drugs Market Size, 2017-2028
6.3.3 Canada Anti-fungal Drugs Market Size, 2017-2028
6.3.4 Mexico Anti-fungal Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country – Europe Anti-fungal Drugs Revenue, 2017-2028
6.4.2 Germany Anti-fungal Drugs Market Size, 2017-2028
6.4.3 France Anti-fungal Drugs Market Size, 2017-2028
6.4.4 U.K. Anti-fungal Drugs Market Size, 2017-2028
6.4.5 Italy Anti-fungal Drugs Market Size, 2017-2028
6.4.6 Russia Anti-fungal Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Anti-fungal Drugs Market Size, 2017-2028
6.4.8 Benelux Anti-fungal Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region – Asia Anti-fungal Drugs Revenue, 2017-2028
6.5.2 China Anti-fungal Drugs Market Size, 2017-2028
6.5.3 Japan Anti-fungal Drugs Market Size, 2017-2028
6.5.4 South Korea Anti-fungal Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Anti-fungal Drugs Market Size, 2017-2028
6.5.6 India Anti-fungal Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country – South America Anti-fungal Drugs Revenue, 2017-2028
6.6.2 Brazil Anti-fungal Drugs Market Size, 2017-2028
6.6.3 Argentina Anti-fungal Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Anti-fungal Drugs Revenue, 2017-2028
6.7.2 Turkey Anti-fungal Drugs Market Size, 2017-2028
6.7.3 Israel Anti-fungal Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Anti-fungal Drugs Market Size, 2017-2028
6.7.5 UAE Anti-fungal Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Anti-fungal Drugs Major Product Offerings
7.1.4 Abbott Laboratories Anti-fungal Drugs Revenue in Global Market (2017-2022)
7.1.5 Abbott Laboratories Key News
7.2 Astellas Pharma
7.2.1 Astellas Pharma Corporate Summary
7.2.2 Astellas Pharma Business Overview
7.2.3 Astellas Pharma Anti-fungal Drugs Major Product Offerings
7.2.4 Astellas Pharma Anti-fungal Drugs Revenue in Global Market (2017-2022)
7.2.5 Astellas Pharma Key News
7.3 Bayer
7.3.1 Bayer Corporate Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Anti-fungal Drugs Major Product Offerings
7.3.4 Bayer Anti-fungal Drugs Revenue in Global Market (2017-2022)
7.3.5 Bayer Key News
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Corporate Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Anti-fungal Drugs Major Product Offerings
7.4.4 GlaxoSmithKline Anti-fungal Drugs Revenue in Global Market (2017-2022)
7.4.5 GlaxoSmithKline Key News
7.5 Glenmark
7.5.1 Glenmark Corporate Summary
7.5.2 Glenmark Business Overview
7.5.3 Glenmark Anti-fungal Drugs Major Product Offerings
7.5.4 Glenmark Anti-fungal Drugs Revenue in Global Market (2017-2022)
7.5.5 Glenmark Key News
7.6 Kramer Laboratories
7.6.1 Kramer Laboratories Corporate Summary
7.6.2 Kramer Laboratories Business Overview
7.6.3 Kramer Laboratories Anti-fungal Drugs Major Product Offerings
7.6.4 Kramer Laboratories Anti-fungal Drugs Revenue in Global Market (2017-2022)
7.6.5 Kramer Laboratories Key News
7.7 Merck
7.7.1 Merck Corporate Summary
7.7.2 Merck Business Overview
7.7.3 Merck Anti-fungal Drugs Major Product Offerings
7.7.4 Merck Anti-fungal Drugs Revenue in Global Market (2017-2022)
7.7.5 Merck Key News
7.8 Novartis
7.8.1 Novartis Corporate Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Anti-fungal Drugs Major Product Offerings
7.8.4 Novartis Anti-fungal Drugs Revenue in Global Market (2017-2022)
7.8.5 Novartis Key News
7.9 Pfizer
7.9.1 Pfizer Corporate Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Anti-fungal Drugs Major Product Offerings
7.9.4 Pfizer Anti-fungal Drugs Revenue in Global Market (2017-2022)
7.9.5 Pfizer Key News
7.10 SCYNEXIS
7.10.1 SCYNEXIS Corporate Summary
7.10.2 SCYNEXIS Business Overview
7.10.3 SCYNEXIS Anti-fungal Drugs Major Product Offerings
7.10.4 SCYNEXIS Anti-fungal Drugs Revenue in Global Market (2017-2022)
7.10.5 SCYNEXIS Key News
7.11 Sanofi
7.11.1 Sanofi Corporate Summary
7.11.2 Sanofi Business Overview
7.11.3 Sanofi Anti-fungal Drugs Major Product Offerings
7.11.4 Sanofi Anti-fungal Drugs Revenue in Global Market (2017-2022)
7.11.5 Sanofi Key News
7.12 Gilead Science
7.12.1 Gilead Science Corporate Summary
7.12.2 Gilead Science Business Overview
7.12.3 Gilead Science Anti-fungal Drugs Major Product Offerings
7.12.4 Gilead Science Anti-fungal Drugs Revenue in Global Market (2017-2022)
7.12.5 Gilead Science Key News
7.13 Enzon Pharmaceuticals
7.13.1 Enzon Pharmaceuticals Corporate Summary
7.13.2 Enzon Pharmaceuticals Business Overview
7.13.3 Enzon Pharmaceuticals Anti-fungal Drugs Major Product Offerings
7.13.4 Enzon Pharmaceuticals Anti-fungal Drugs Revenue in Global Market (2017-2022)
7.13.5 Enzon Pharmaceuticals Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Anti-fungal Drugs Market Opportunities & Trends in Global Market
Table 2. Anti-fungal Drugs Market Drivers in Global Market
Table 3. Anti-fungal Drugs Market Restraints in Global Market
Table 4. Key Players of Anti-fungal Drugs in Global Market
Table 5. Top Anti-fungal Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Anti-fungal Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Anti-fungal Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Anti-fungal Drugs Product Type
Table 9. List of Global Tier 1 Anti-fungal Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-fungal Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Anti-fungal Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Anti-fungal Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Anti-fungal Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Anti-fungal Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Anti-fungal Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Anti-fungal Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Anti-fungal Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Anti-fungal Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Anti-fungal Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Anti-fungal Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Anti-fungal Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Anti-fungal Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Anti-fungal Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Anti-fungal Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Anti-fungal Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Anti-fungal Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Anti-fungal Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Anti-fungal Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Anti-fungal Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Anti-fungal Drugs Product Offerings
Table 32. Abbott Laboratories Anti-fungal Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Astellas Pharma Corporate Summary
Table 34. Astellas Pharma Anti-fungal Drugs Product Offerings
Table 35. Astellas Pharma Anti-fungal Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Bayer Corporate Summary
Table 37. Bayer Anti-fungal Drugs Product Offerings
Table 38. Bayer Anti-fungal Drugs Revenue (US$, Mn), (2017-2022)
Table 39. GlaxoSmithKline Corporate Summary
Table 40. GlaxoSmithKline Anti-fungal Drugs Product Offerings
Table 41. GlaxoSmithKline Anti-fungal Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Glenmark Corporate Summary
Table 43. Glenmark Anti-fungal Drugs Product Offerings
Table 44. Glenmark Anti-fungal Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Kramer Laboratories Corporate Summary
Table 46. Kramer Laboratories Anti-fungal Drugs Product Offerings
Table 47. Kramer Laboratories Anti-fungal Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Merck Corporate Summary
Table 49. Merck Anti-fungal Drugs Product Offerings
Table 50. Merck Anti-fungal Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Novartis Corporate Summary
Table 52. Novartis Anti-fungal Drugs Product Offerings
Table 53. Novartis Anti-fungal Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Pfizer Corporate Summary
Table 55. Pfizer Anti-fungal Drugs Product Offerings
Table 56. Pfizer Anti-fungal Drugs Revenue (US$, Mn), (2017-2022)
Table 57. SCYNEXIS Corporate Summary
Table 58. SCYNEXIS Anti-fungal Drugs Product Offerings
Table 59. SCYNEXIS Anti-fungal Drugs Revenue (US$, Mn), (2017-2022)
Table 60. Sanofi Corporate Summary
Table 61. Sanofi Anti-fungal Drugs Product Offerings
Table 62. Sanofi Anti-fungal Drugs Revenue (US$, Mn), (2017-2022)
Table 63. Gilead Science Corporate Summary
Table 64. Gilead Science Anti-fungal Drugs Product Offerings
Table 65. Gilead Science Anti-fungal Drugs Revenue (US$, Mn), (2017-2022)
Table 66. Enzon Pharmaceuticals Corporate Summary
Table 67. Enzon Pharmaceuticals Anti-fungal Drugs Product Offerings
Table 68. Enzon Pharmaceuticals Anti-fungal Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Anti-fungal Drugs Segment by Type in 2021
Figure 2. Anti-fungal Drugs Segment by Application in 2021
Figure 3. Global Anti-fungal Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Anti-fungal Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Anti-fungal Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-fungal Drugs Revenue in 2021
Figure 8. By Type - Global Anti-fungal Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Anti-fungal Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Anti-fungal Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Anti-fungal Drugs Revenue Market Share, 2017-2028
Figure 12. US Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Anti-fungal Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Anti-fungal Drugs Revenue Market Share, 2017-2028
Figure 24. China Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Anti-fungal Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Anti-fungal Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Anti-fungal Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Anti-fungal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Astellas Pharma Anti-fungal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bayer Anti-fungal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. GlaxoSmithKline Anti-fungal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Glenmark Anti-fungal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Kramer Laboratories Anti-fungal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck Anti-fungal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Novartis Anti-fungal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pfizer Anti-fungal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. SCYNEXIS Anti-fungal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Sanofi Anti-fungal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Gilead Science Anti-fungal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Enzon Pharmaceuticals Anti-fungal Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 抗真菌剤の世界市場見通し2022年-2028年(Anti-fungal Drugs Market, Global Outlook and Forecast 2022-2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆